Navigation Links
Gilead Announces Presentation of Long-Term Data for Ambrisentan, a,Potential Treatment for Patients With Pulmonary Arterial,Hypertension

wn underlying cause, or it can occur secondary to diseases such as connective tissue disease, congenital heart defects, cirrhosis of the liver and HIV infection. PAH afflicts approximately 200,000 patients worldwide.

About Gilead Sciences

Gilead Sciences is a biopharmaceutical company that discovers, develops and commercializes innovative therapeutics in areas of unmet medical need. The company's mission is to advance the care of patients suffering from life-threatening diseases worldwide. Headquartered in Foster City, California, Gilead has operations in North America, Europe and Australia. For more information on Gilead Sciences, please visit the company's website at www.gilead.com or call Gilead Public Affairs at 1-800-GILEAD-5 or 1-650-574-3000.

This press release includes forward-looking statements, within the meaning of the Private Securities Litigation Reform Act of 1995, that are subject to risks, uncertainties and other factors, including risks related to Gilead's ability to successfully commercialize ambrisentan for PAH. For example, the FDA may not approve ambrisentan for the treatment of PAH in the United States, and marketing approval, if granted, may have significant limitations on its use. In addition, future discussions with the FDA may impact the amount of data needed and timelines for review, which may differ materially from Gilead's current projections. Further, safety and efficacy data from additional clinical studies may not warrant further development of this compound and completing our clinical studies may take longer or cost more than expected. These risks, uncertainties and other factors could cause actual results to differ materially from those referred to in the forward-looking statements. The reader is cautioned not to rely on these forward-looking statements. These and other risks are described in detail in Gilead's Annual Report on Form 10-K for the year ended December 31, 2006 and its Report on Form 10-Q for the fi
'"/>




Page: 1 2 3 4 5 6

Related medicine technology :

1. Second Phase III Study Evaluating Gileads Viread for the Treatment of Chronic Hepatitis B Virus Meets Primary Endpoint
2. Second Phase III Study Evaluating Gileads Viread for the Treatment of Chronic Hepatitis B Virus Meets Primary Endpoint
3. Phase III Study Evaluating Gileads Viread for the Treatment of Chronic Hepatitis B Virus Meets Primary Endpoint
4. Gilead Announces Achievement of Primary Efficacy Endpoint in Second Phase III Study of Aztreonam Lysine for Inhalation in Patients With Cystic Fibrosis
5. Gilead Announces Presentation of Positive Phase III Data on Aztreonam Lysine for Inhalation in Patients With Cystic Fibrosis
6. Data from Preclinical Studies of Gilead Nucleotide Compound GS 9219 to be Presented at AACR
7. Antisoma Announces Further Data From ASA404 Ovarian Cancer Trial
8. Neose Announces Presentation of Positive Preclinical Data on GlycoPEGylated Factor VIIa at the XXI Congress of the International Society on Thrombosis and Haemostasis
9. Biofrontera AG Announces Clinical Study Confirms Excellent Efficacy of BF-200 ALA In Actinic Keratosis
10. YM BioSciences Announces Secondary Efficacy and Safety Findings in Randomized Phase IIB Aerolef Trial
11. BioSante Pharmaceuticals Announces New Findings for Potential Bird Flu Vaccine
Post Your Comments:
(Date:6/2/2015)... , June 2, 2015  Only a quarter of ... managing the patients they prescribe them to, according to ... School of Medicine (BUSM) and myCME , ... Daniel Alford, M.D. , director of BUSM,s ... program , said, "This indicates a critical need for ...
(Date:6/2/2015)... 2015  ErgoNurse, the leader in bedside safety management solutions, ... the United States , have formalized a ... and skilled nursing markets. ... Thousands of healthcare professionals ... advantage of the ErgoNurse products to stop unnecessarily utilizing their ...
(Date:6/2/2015)...  CytRx Corporation (NASDAQ: CYTR ), a biopharmaceutical ... that it has reached an agreement to settle the ... Court of Chancery, which names as defendants ... and officers, and names the Company as a nominal ... CytRx Corp. Stockholder Derivative Litigation , C.A. No. 9864-VCL, ...
Breaking Medicine Technology:Survey Results Show Few Doctors Are Very Confident Managing Patients on Opioids 2ErgoNurse and Briggs Healthcare Positioned to Completely Eliminate the Unnecessary Cost of Healthcare-Related Back Injuries 2CytRx Announces Settlement of Stockholder Derivative Lawsuit in Delaware 2CytRx Announces Settlement of Stockholder Derivative Lawsuit in Delaware 3CytRx Announces Settlement of Stockholder Derivative Lawsuit in Delaware 4
... FRANCISCO, Feb. 19 Inverseon, Inc. ( http://www.inverseon.com ) ... of the Proceedings of the National Academy of Sciences ... of an asthma phenotype in a murine model." The ... Duke Professor of Medicine at Duke University , ...
... France, February 18 , ... in Latin,America and Asia , ... :,SAN and NYSE : SNY), announced today that its ... study in Thailand to,assess the efficacy of the vaccine ...
Cached Medicine Technology:Inverseon's Founder and SAB Member Published in PNAS 2Sanofi Pasteur Dengue Vaccine Enters Pediatric Efficacy Clinical Study 2Sanofi Pasteur Dengue Vaccine Enters Pediatric Efficacy Clinical Study 3Sanofi Pasteur Dengue Vaccine Enters Pediatric Efficacy Clinical Study 4
(Date:6/2/2015)... (PRWEB) June 02, 2015 Erbelli’s Gourmet ... website to promote its handmade gourmet pizzas and calzones, ... though the website is new, the recipes are not—they ... 1995. The main feature of the site is the ... pictures and descriptions of all the items. You can ...
(Date:6/2/2015)... June 02, 2015 MAP Health Management, ... revenue cycle management for addiction treatment facilities, announced today ... President of Marketing. Mr. Smith will be responsible for ... awareness and visibility of MAP’s core message, products and ... the Marketing Manager at Cottonwood Financial in Irving, Texas, ...
(Date:6/2/2015)... June 02, 2015 ANT Wireless, ... highlights North Pole Engineering’s (NPE) announcement of three ... technologies: WASP-N, WASP-PoE-2 and WASP-PoE-3. WASP is a ... Bluetooth Smart® bridge solution that allows data collected ... WiFi or Ethernet networks. , The ...
(Date:6/2/2015)... The health care leaders who established ... value-based care will now offer health coverage for those ... The newly launched Crystal Run Health Plans has received ... Preferred Provider Organization (PPO) and Exclusive Provider Organization (EPO) ... and CEO, Hal Teitelbaum, MD, JD, MBA , ...
(Date:6/2/2015)... (PRWEB) June 02, 2015 National Autism ... creative marketing, web design and development agency, to launch ... , National Autism Resources’ new website is ... of all ages diagnosed with autism. The site will ... offer an array of resources, from easy to understand ...
Breaking Medicine News(10 mins):Health News:Erbelli’s of Bradenton Launches New Mobile-Friendly Website 2Health News:Jared Smith Joins MAP Health Management, LLC, as Vice President of Marketing 2Health News:ANT Technology Incorporated in Second Generation WASP Bridge Products 2Health News:ANT Technology Incorporated in Second Generation WASP Bridge Products 3Health News:Leading Health Care Innovator Poised to Deliver New Health Coverage Options To The Hudson Valley Region 2Health News:Leading Health Care Innovator Poised to Deliver New Health Coverage Options To The Hudson Valley Region 3Health News:National Autism Resources Launches New Website, Delivering More Products and Services 2Health News:National Autism Resources Launches New Website, Delivering More Products and Services 3
... been mapped to the smallest fold for at least a century, ... each other. A study in Proceedings of the ... area of the rat brain and in so doing takes a ... brain connections was thought too complex to describe, but molecular biology ...
... Gardner HealthDay Reporter , MONDAY, Aug. 9 (HealthDay ... may spot Alzheimer,s disease long before symptoms start and might ... The findings, appearing in the August issue of the ... touting the use of such proteins, also known as biomarkers, ...
... Everyone experiences social stress, whether it is nervousness over ... angst over giving a speech. In a new report, ... to social stressors can influence the body,s immune system ... Lead author George Slavich, a postdoctoral fellow at ...
... Jenifer Goodwin HealthDay Reporter , MONDAY, Aug. 9 (HealthDay ... American girls, with many girls as young as 7 and 8 ... Rising rates of childhood obesity -- long linked to earlier sexual ... study, more than 1,200 girls ages 6 to 8 from Cincinnati, ...
... for oral cancer, which a dentist could perform by simply ... is set to be developed by researchers at the University ... The international research team, involving scientists in Sheffield, has ... Health to develop the test, which could provide an accurate ...
... cells," which help the brain map locations, have been found ... rat brain, according to new research from the Norwegian University ... our understanding of how the brain generates the internal maps ... to get to where we want to go. Five ...
Cached Medicine News:Health News:Brain's wiring: More network than pyramid? 2Health News:'Biomarkers' Could Spot Alzheimer's Disease Early, Studies Suggest 2Health News:'Biomarkers' Could Spot Alzheimer's Disease Early, Studies Suggest 3Health News:Stress gets under our skin 2Health News:Stress gets under our skin 3Health News:Many Girls Now Begin Puberty at Age 7, 8 2Health News:Many Girls Now Begin Puberty at Age 7, 8 3Health News:New 'dentist' test to detect oral cancer will save lives 2Health News:New 'dentist' test to detect oral cancer will save lives 3
For support, strength and control in your interventions, the RunWay Guide Catheter's large lumen and high-performance design represents a new era in guide catheters....
... developed over Guidants 20-year history, the VOYAGER ... for successful treatment outcomes. It combines a ... a lower profile shaft,more flexible markers, and ... cross tight and tortuous anatomy with even ...
... Utilizing technology developed over Guidants 20-year history, ... new foundation for successful treatment outcomes. It ... design with a lower profile shaft,more flexible ... you can cross tight and tortuous anatomy ...
Test for AFP...
Medicine Products: